[Sweden approved of Depo-Provera sales promotion in developing countries. Interview by Elisabeth Magnusson].
D000329:Advertising; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D003906:Developing Countries; D004345:Drug Industry; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects*; D013548:Sweden
D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D008525:Medroxyprogesterone
Sveriges godkännande av Depo-Provera försäljningsargument i u-länderna.